RANDOMIZED TRIAL OF ASPRIN AS ADJUVANT THERAPY FOR NODE-POSITIVE BREAST CANCER

$3,287,259FY2015Department of the ArmyDOD

Dana-Farber Cancer Institute, Inc.

Investigators

View source on USAspending →